Cervical and Thoracic Spondylotic Myelopathies

Abstract

Spondylotic myelopathies are among the most common disorders of the spine, yet the clinical and treatment approach is far from standardized. This article discusses our current understanding of the epidemiology, pathophysiology, clinical assessment, natural history, and treatment options in degenerative myelopathies of the cervical and thoracic spine. We additionally review diagnostic modalities including imaging modalities of the spine and neurophysiological tools such as electromyography/nerve conduction studies, somatosensory-evoked potentials, and motor-evoked potentials. Assessment instruments that can be used for the assessment of myelopathies are reviewed, including the Japanese Orthopedic Association (JOA) score, modified-JOA scale, Nurick scale, nine-hole peg test, and 30-m walking test. We also review common disorders that mimic spondylotic myelopathies, as well as helpful diagnostic clues in differentiating spondylotic and nonspondylotic myelopathies.

Keywords

cervical myelopathy - thoracic myelopathy - degenerative myelopathies

Publikationsverlauf

Artikel online veröffentlicht:
19. Mai 2021

• References

• 1 Bartleson JD, Deen HG. Spine Disorders: Medical and Surgical Management. Cambridge; New York, NY:: Cambridge University Press; 2009
• 2 Yamaguchi S, Mitsuhara T, Abiko M, Takeda M, Kurisu K. Epidemiology and overview of the clinical spectrum of degenerative cervical myelopathy. Neurosurg Clin N Am 2018; 29 (01) 1-12
• 3 Aizawa T, Sato T, Tanaka Y. et al. Thoracic myelopathy in Japan: epidemiological retrospective study in Miyagi Prefecture during 15 years. Tohoku J Exp Med 2006; 210 (03) 199-208
• 4 Karadimas SK, Erwin WM, Ely CG, Dettori JR, Fehlings MG. Pathophysiology and natural history of cervical spondylotic myelopathy. Spine 2013; 38 (22, Suppl 1): S21-S36
• 5 Wilson JR, Tetreault LA, Kim J. et al. State of the art in degenerative cervical myelopathy: an update on current clinical evidence. Neurosurgery 2017; 80 (3S): S33-S45
• 6 Jenkins TJ, Mai HT, Burgmeier RJ, Savage JW, Patel AA, Hsu WK. The triangle model of congenital cervical stenosis. Spine 2016; 41 (05) E242-E247
• 7 Hou X, Sun C, Liu X. et al. Clinical features of thoracic spinal stenosis-associated myelopathy: a retrospective analysis of 427 cases. Clin Spine Surg 2016; 29 (02) 86-89
• 8 Dvorak J, Sutter M, Herdmann J. Cervical myelopathy: clinical and neurophysiological evaluation. Eur Spine J 2003; 12 (Suppl. 02) S181-S187
• 9 Amenta PS, Ghobrial GM, Krespan K, Nguyen P, Ali M, Harrop JS. Cervical spondylotic myelopathy in the young adult: a review of the literature and clinical diagnostic criteria in an uncommon demographic. Clin Neurol Neurosurg 2014; 120: 68-72
• 10 Chikuda H, Seichi A, Takeshita K. et al. Correlation between pyramidal signs and the severity of cervical myelopathy. Eur Spine J 2010; 19 (10) 1684-1689
• 11 Takayama H, Muratsu H, Doita M, Harada T, Kurosaka M, Yoshiya S. Proprioceptive recovery of patients with cervical myelopathy after surgical decompression. Spine 2005; 30 (09) 1039-1044
• 12 Wang Z, Sakakibara T, Kasai Y. Overactive bladder in cervical spondylotic myelopathy. J Orthop Sci 2014; 19 (01) 22-25
• 13 Hehir MK, Figueroa JJ, Zynda-Weiss AM, Stanton M, Logigian EL. Unexpected neuroimaging abnormalities in patients with apparent C8 radiculopathy: broadening the clinical spectrum. Muscle Nerve 2012; 45 (06) 859-865
• 14 Olindo S, Signate A, Richech A. et al. Quantitative assessment of hand disability by the Nine-Hole-Peg test (9-HPT) in cervical spondylotic myelopathy. J Neurol Neurosurg Psychiatry 2008; 79 (08) 965-967
• 15 Oxford Grice K, Vogel KA, Le V, Mitchell A, Muniz S, Vollmer MA. Adult norms for a commercially available Nine Hole Peg Test for finger dexterity. Am J Occup Ther 2003; 57 (05) 570-573
• 16 Singh A, Crockard HA. Quantitative assessment of cervical spondylotic myelopathy by a simple walking test. Lancet 1999; 354 (9176): 370-373
• 17 Bohm PE, Fehlings MG, Kopjar B. et al. Psychometric properties of the 30-m walking test in patients with degenerative cervical myelopathy: results from two prospective multicenter cohort studies. Spine J 2017; 17 (02) 211-217
• 18 Siasios ID, Spanos SL, Kanellopoulos AK. et al. The role of gait analysis in the evaluation of patients with cervical myelopathy: a literature review study. World Neurosurg 2017; 101: 275-282
• 19 Kato S, Oshima Y, Oka H. et al. Comparison of the Japanese Orthopaedic Association (JOA) score and modified JOA (mJOA) score for the assessment of cervical myelopathy: a multicenter observational study. PLoS One 2015; 10 (04) e0123022
• 20 Tetreault L, Kopjar B, Nouri A. et al. The modified Japanese Orthopaedic Association scale: establishing criteria for mild, moderate and severe impairment in patients with degenerative cervical myelopathy. Eur Spine J 2017; 26 (01) 78-84
• 21 Vitzthum HE, Dalitz K. Analysis of five specific scores for cervical spondylogenic myelopathy. Eur Spine J 2007; 16 (12) 2096-2103
• 22 Flanagan EP, Krecke KN, Marsh RW, Giannini C, Keegan BM, Weinshenker BG. Specific pattern of gadolinium enhancement in spondylotic myelopathy. Ann Neurol 2014; 76 (01) 54-65
• 23 Simon NG, Lomen-Hoerth C, Kiernan MC. Patterns of clinical and electrodiagnostic abnormalities in early amyotrophic lateral sclerosis. Muscle Nerve 2014; 50 (06) 894-899
• 24 Hammad M, Silva A, Glass J, Sladky JT, Benatar M. Clinical, electrophysiologic, and pathologic evidence for sensory abnormalities in ALS. Neurology 2007; 69 (24) 2236-2242
• 25 Magge SN, Smyth MD, Governale LS. et al. Idiopathic syrinx in the pediatric population: a combined center experience. J Neurosurg Pediatr 2011; 7 (01) 30-36
• 26 Milhorat TH, Chou MW, Trinidad EM. et al. Chiari I malformation redefined: clinical and radiographic findings for 364 symptomatic patients. Neurosurgery 1999; 44 (05) 1005-1017
• 27 Lyu RK, Huang YC, Wu YR. et al. Electrophysiological features of Hirayama disease. Muscle Nerve 2011; 44 (02) 185-190
• 28 Verschueren A, Azulay JP, Attarian S, Boucraut J, Pellissier JF, Pouget J. Lewis-Sumner syndrome and multifocal motor neuropathy. Muscle Nerve 2005; 31 (01) 88-94
• 29 Krings T, Geibprasert S. Spinal dural arteriovenous fistulas. AJNR Am J Neuroradiol 2009; 30 (04) 639-648
• 30 Shiban E, Meyer B. Treatment considerations of cervical spondylotic myelopathy. Neurol Clin Pract 2014; 4 (04) 296-303
• 31 Xu N, Wang S, Yuan H, Liu X, Liu Z. Does dynamic supine magnetic resonance imaging improve the diagnostic accuracy of cervical spondylotic myelopathy? A review of the current evidence. World Neurosurg 2017; 100: 474-479
• 32 Liu Y, Kong C, Cui L. et al. Correlation between diffusion tensor imaging parameters and clinical assessments in patients with cervical spondylotic myelopathy with and without high signal intensity. Spinal Cord 2017; 55 (12) 1079-1083
• 33 Clarke E, Robinson PK. Cervical myelopathy: a complication of cervical spondylosis. Brain 1956; 79 (03) 483-510
• 34 Rhee J, Tetreault LA, Chapman JR. et al. Nonoperative versus operative management for the treatment degenerative cervical myelopathy: an updated systematic review. Global Spine J 2017; 7 (3, Suppl): 35S-41S
• 35 Witiw CD, Tetreault LA, Smieliauskas F, Kopjar B, Massicotte EM, Fehlings MG. Surgery for degenerative cervical myelopathy: a patient-centered quality of life and health economic evaluation. Spine J 2017; 17 (01) 15-25
• 36 Kadaňka Z, Bednařík J, Novotný O, Urbánek I, Dušek L. Cervical spondylotic myelopathy: conservative versus surgical treatment after 10 years. Eur Spine J 2011; 20 (09) 1533-1538
• 37 Tetreault LA, Côté P, Kopjar B, Arnold P, Fehlings MG. AOSpine North America and International Clinical Trial Research Network. A clinical prediction model to assess surgical outcome in patients with cervical spondylotic myelopathy: internal and external validations using the prospective multicenter AOSpine North American and international datasets of 743 patients. Spine J 2015; 15 (03) 388-397
• 38 Fehlings MG, Barry S, Kopjar B. et al. Anterior versus posterior surgical approaches to treat cervical spondylotic myelopathy: outcomes of the prospective multicenter AOSpine North America CSM study in 264 patients. Spine 2013; 38 (26) 2247-2252
• 39 Kalsi-Ryan S, Singh A, Massicotte EM. et al. Ancillary outcome measures for assessment of individuals with cervical spondylotic myelopathy. Spine 2013; 38 (22, Suppl 1): S111-S122
• 40 Toledano M, Bartleson JD. Cervical spondylotic myelopathy. Neurol Clin 2013; 31 (01) 287-305